CELLINK empowers the Swedish 3Rs Center´s network to create awareness on how to reduce animal testing

BICO strengthens IP portfolio with two additional patents for 3D bioprinting

BICO Launches 3D Bioprinting Contract Research Offering From CELLINK, MatTek and Visikol

CELLINK has entered into an agreement to acquire Discover Echo Inc.

CELLINK has acquired Visikol

CELLINK has entered into an agreement to acquire Nanoscribe

CELLINK receives the prestigious gold award for the BIO X6 and wins two design excellence awards for the C.WASH and UP.SIGHT at the iF Design Awards 2021

CELLINK and UPM Biomedicals has formed a collaboration for ground-breaking 3D bioprinting developments

BIO X6 wins prestigious Red Dot Design Award for outstanding design quality

CELLINK launches the BIO MDX Series, a scaled-up revolution in biomedical manufacturing

CELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion

CELLINK has entered into an agreement to acquire MatTek, the global leader in in-vitro technology and alternative drug testing models